Activity of the Raf kinase inhibitor BAY 43-9006 in patients with advanced solid tumors.

Journal: Clinical colorectal cancer 2003;3(1):16-8

PMID: 12777188

Full Text on Elsevier Science View on PubMed

Abstract

DOI: 10.1016/s1533-0028(11)70463-7

Link outs

Free resources

Medical:

https://medlineplus.gov/colorectalcancer.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Miscellaneous:

https://assays.cancer.gov/CPTAC-1335

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-RAF1-4

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S1533...
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Benzenesulfonates, Clinical Trials, Phase I as Topic, Colorectal Neoplasms, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Middle Aged, Niacinamide, Phenylurea Compounds, Proto-Oncogene Proteins c-raf, Pyridines, Sorafenib

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.